TreeWAS – Variant ID: rs2008242

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I42.9 Cardiomyopathy, unspecified	0.000	0.935	0.065
I42 Cardiomyopathy	0.000	0.970	0.030
L03.0 Cellulitis of finger and toe	0.000	0.975	0.025
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.975	0.025
I42.6 Alcoholic cardiomyopathy	0.000	0.976	0.024
I42.5 Other restrictive cardiomyopathy	0.000	0.976	0.024
C54.1 Endometrium	0.022	0.978	0.000
I42.0 Dilated cardiomyopathy	0.000	0.978	0.022
I42.4 Endocardial fibroelastosis	0.000	0.978	0.021
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.978	0.021
I42.8 Other cardiomyopathies	0.000	0.980	0.020
I42.2 Other hypertrophic cardiomyopathy	0.000	0.981	0.019
Y45.1 Salicylates	0.018	0.982	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.015	0.985	0.000
C54 Malignant neoplasm of corpus uteri	0.014	0.986	0.000
M54.22 Cervicalgia (Cervical region)	0.000	0.986	0.014
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.987	0.012
C54.9 Corpus uteri, unspecified	0.012	0.988	0.000
C02.9 Tongue, unspecified	0.012	0.988	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.012	0.988	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.011	0.989	0.000
C54.8 Overlapping lesion of corpus uteri	0.010	0.990	0.000
C54.3 Fundus uteri	0.010	0.990	0.000
C54.2 Myometrium	0.010	0.990	0.000
C54.0 Isthmus uteri	0.010	0.990	0.000
C02.1 Border of tongue	0.009	0.991	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.009	0.991	0.000
K81.0 Acute cholecystitis	0.000	0.991	0.009
C02.2 Ventral surface of tongue	0.009	0.991	0.000
Y45.4 Antirheumatics	0.009	0.991	0.000
Y45.5 4-Aminophenol derivatives	0.008	0.992	0.000
C02.0 Dorsal surface of tongue	0.008	0.992	0.000
C02.8 Overlapping lesion of tongue	0.008	0.992	0.000
C02.4 Lingual tonsil	0.008	0.992	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.008	0.992	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.007	0.993	0.000
C07 Malignant neoplasm of parotid gland	0.007	0.993	0.000
Y45.8 Other analgesics and antipyretics	0.007	0.993	0.000
C12 Malignant neoplasm of pyriform sinus	0.007	0.993	0.000
C09 Malignant neoplasm of tonsil	0.007	0.993	0.000
H60.9 Otitis externa, unspecified	0.000	0.993	0.007
C04 Malignant neoplasm of floor of mouth	0.006	0.994	0.000
C13 Malignant neoplasm of hypopharynx	0.006	0.994	0.000
C00 Malignant neoplasm of lip	0.006	0.994	0.000
M79.67 Pain in limb (Ankle and foot)	0.006	0.994	0.000
C10 Malignant neoplasm of oropharynx	0.006	0.994	0.000
C01 Malignant neoplasm of base of tongue	0.006	0.994	0.000
C03 Malignant neoplasm of gum	0.006	0.994	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.005	0.994	0.000
C09.9 Tonsil, unspecified	0.006	0.994	0.000
C71.9 Brain, unspecified	0.000	0.994	0.006
C71 Malignant neoplasm of brain	0.000	0.995	0.005
C09.0 Tonsillar fossa	0.005	0.995	0.000
C04.9 Floor of mouth, unspecified	0.005	0.995	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.005	0.995	0.000
C71.1 Frontal lobe	0.000	0.995	0.005
C13.9 Hypopharynx, unspecified	0.005	0.995	0.000
C04.0 Anterior floor of mouth	0.005	0.995	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.005	0.995	0.000
C71.4 Occipital lobe	0.000	0.995	0.005
C09.8 Overlapping lesion of tonsil	0.005	0.995	0.000
C11 Malignant neoplasm of nasopharynx	0.005	0.995	0.000
I49.9 Cardiac arrhythmia, unspecified	0.005	0.995	0.000
C04.8 Overlapping lesion of floor of mouth	0.005	0.995	0.000
C04.1 Lateral floor of mouth	0.005	0.995	0.000
C00.9 Lip, unspecified	0.005	0.995	0.000
I51.9 Heart disease, unspecified	0.000	0.995	0.005
I44.7 Left bundle-branch block, unspecified	0.000	0.995	0.005
C13.8 Overlapping lesion of hypopharynx	0.005	0.995	0.000
C13.2 Posterior wall of hypopharynx	0.005	0.995	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.005	0.995	0.000
C71.3 Parietal lobe	0.000	0.995	0.005
C13.0 Postcricoid region	0.005	0.995	0.000
C00.1 External lower lip	0.004	0.995	0.000
Q23.1 Congenital insufficiency of aortic valve	0.000	0.995	0.005
C00.8 Overlapping lesion of lip	0.004	0.995	0.000
C00.6 Commissure of lip	0.004	0.995	0.000
C00.5 Lip, unspecified, inner aspect	0.004	0.995	0.000
C00.4 Lower lip, inner aspect	0.004	0.995	0.000
C00.3 Upper lip, inner aspect	0.004	0.995	0.000
C00.2 External lip, unspecified	0.004	0.995	0.000
C06.2 Retromolar area	0.004	0.995	0.000
C00.0 External upper lip	0.004	0.995	0.000
C10.9 Oropharynx, unspecified	0.004	0.995	0.000
C10.8 Overlapping lesion of oropharynx	0.004	0.996	0.000
C10.4 Branchial cleft	0.004	0.996	0.000
C10.3 Posterior wall of oropharynx	0.004	0.996	0.000
C10.2 Lateral wall of oropharynx	0.004	0.996	0.000
C10.1 Anterior surface of epiglottis	0.004	0.996	0.000
C10.0 Vallecula	0.004	0.996	0.000
C71.8 Overlapping lesion of brain	0.000	0.996	0.004
K80.8 Other cholelithiasis	0.004	0.996	0.000
Y45.2 Propionic acid derivatives	0.004	0.996	0.001
C03.9 Gum, unspecified	0.004	0.996	0.000
C03.0 Upper gum	0.004	0.996	0.000
C71.2 Temporal lobe	0.000	0.996	0.004
J38.1 Polyp of vocal cord and larynx	0.000	0.996	0.004
M54.2 Cervicalgia	0.000	0.996	0.004
C14.2 Waldeyer's ring	0.004	0.996	0.000
C71.5 Cerebral ventricle	0.000	0.996	0.004
C71.6 Cerebellum	0.000	0.996	0.004
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.004	0.996	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.996	0.004
C08 Malignant neoplasm of other and unspecified major salivary glands	0.004	0.996	0.001
C14.0 Pharynx, unspecified	0.004	0.996	0.000
C03.1 Lower gum	0.004	0.996	0.000
I47.2 Ventricular tachycardia	0.000	0.996	0.004
C11.1 Posterior wall of nasopharynx	0.004	0.996	0.000
C05 Malignant neoplasm of palate	0.004	0.996	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.004	0.996	0.000
C06.1 Vestibule of mouth	0.004	0.996	0.000
Q23 Congenital malformations of aortic and mitral valves	0.000	0.996	0.004
C71.7 Brain stem	0.000	0.996	0.004
D86.9 Sarcoidosis, unspecified	0.004	0.996	0.000
C11.8 Overlapping lesion of nasopharynx	0.004	0.996	0.000
C11.3 Anterior wall of nasopharynx	0.004	0.996	0.000
C11.2 Lateral wall of nasopharynx	0.004	0.996	0.000
C11.0 Superior wall of nasopharynx	0.004	0.996	0.000
K80.4 Calculus of bile duct with cholecystitis	0.004	0.996	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.004	0.996	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.996	0.004
Y57.5 X-ray contrast media	0.004	0.996	0.000
C51-C58 Malignant neoplasms of female genital organs	0.004	0.996	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.996	0.004
L71.9 Rosacea, unspecified	0.000	0.996	0.004
Y45.0 Opioids and related analgesics	0.003	0.996	0.000
Q23.0 Congenital stenosis of aortic valve	0.000	0.996	0.003
I51 Complications and ill-defined descriptions of heart disease	0.000	0.996	0.004
Q38.7 Pharyngeal pouch	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
C06.9 Mouth, unspecified	0.003	0.997	0.000
M54.4 Lumbago with sciatica	0.000	0.997	0.003
M54.27 Cervicalgia-Lumbosacral	0.000	0.997	0.003
M54.26 Cervicalgia-Lumbar	0.000	0.997	0.003
M54.25 Cervicalgia-Thoracolumbar	0.000	0.997	0.003
M54.24 Cervicalgia-Thoracic	0.000	0.997	0.003
M54.20 Cervicalgia-Mult site	0.000	0.997	0.003
I51.3 Intracardiac thrombosis, not elsewhere classified	0.000	0.997	0.003
C51 Malignant neoplasm of vulva	0.003	0.997	0.000
C08.8 Overlapping lesion of major salivary glands	0.003	0.997	0.001
C08.1 Sublingual gland	0.003	0.997	0.001
C06.0 Cheek mucosa	0.003	0.997	0.000
T14.1 Open wound of unspecified body region	0.000	0.997	0.003
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.997	0.003
Q24 Other congenital malformations of heart	0.000	0.997	0.003
I51.4 Myocarditis, unspecified	0.000	0.997	0.003
Q24.8 Other specified congenital malformations of heart	0.000	0.997	0.003
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.997	0.003
C05.8 Overlapping lesion of palate	0.003	0.997	0.000
C05.2 Uvula	0.003	0.997	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.000	0.997	0.003
I51.1 Rupture of chordae tendineae, not elsewhere classified	0.000	0.997	0.003
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.997	0.003
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.000	0.997	0.003
Q23.8 Other congenital malformations of aortic and mitral valves	0.000	0.997	0.003
Q23.4 Hypoplastic left heart syndrome	0.000	0.997	0.003
Q23.2 Congenital mitral stenosis	0.000	0.997	0.003
C05.9 Palate, unspecified	0.003	0.997	0.000
D86 Sarcoidosis	0.003	0.997	0.000
T14 Injury of unspecified body region	0.000	0.997	0.003
C51.9 Vulva, unspecified	0.003	0.997	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.003	0.997	0.000
D80 Immunodeficiency with predominantly antibody defects	0.003	0.997	0.000
Q28 Other congenital malformations of circulatory system	0.000	0.997	0.003
C55 Malignant neoplasm of uterus, part unspecified	0.003	0.997	0.000
T14.0 Superficial injury of unspecified body region	0.000	0.997	0.003
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.003	0.997	0.000
D86.1 Sarcoidosis of lymph nodes	0.003	0.997	0.000
L50.9 Urticaria, unspecified	0.000	0.997	0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
D86.8 Sarcoidosis of other and combined sites	0.003	0.997	0.000
Q23.3 Congenital mitral insufficiency	0.000	0.997	0.003
C08.0 Submandibular gland	0.002	0.997	0.001
Q24.9 Congenital malformation of the heart, unspecified	0.000	0.997	0.003
C58 Malignant neoplasm of placenta	0.003	0.997	0.000
C11.9 Nasopharynx, unspecified	0.002	0.997	0.001
M54.29 Cervicalgia-Site unspe	0.000	0.997	0.003
H60 Otitis externa	0.000	0.997	0.003
I51.2 Rupture of papillary muscle, not elsewhere classified	0.000	0.997	0.003
Q27 Other congenital malformations of peripheral vascular system	0.000	0.997	0.003
I51.6 Cardiovascular disease, unspecified	0.000	0.997	0.003
T14.6 Injury of tendons and muscles of unspecified body region	0.000	0.997	0.003
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
C05.0 Hard palate	0.002	0.997	0.001
T14.4 Injury of nerve(s) of unspecified body region	0.000	0.997	0.003
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
H60.3 Other infective otitis externa	0.000	0.997	0.003
C52 Malignant neoplasm of vagina	0.003	0.997	0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.997	0.003
M54.44 Lumbago with sciatica-Thoracic	0.000	0.997	0.003
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.997	0.003
M54.42 Lumbago with sciatica-Cervical	0.000	0.997	0.003
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.997	0.003
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.997	0.003
I51.5 Myocardial degeneration	0.000	0.997	0.003
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.997	0.003
H60.5 Acute otitis externa, non-infective	0.000	0.997	0.003
C51.1 Labium minus	0.003	0.997	0.000
C51.0 Labium majus	0.003	0.997	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.000	0.997	0.003
T14.9 Injury, unspecified	0.000	0.997	0.003
C08.9 Major salivary gland, unspecified	0.002	0.997	0.001
C51.8 Overlapping lesion of vulva	0.002	0.997	0.000
C51.2 Clitoris	0.002	0.997	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.000	0.997	0.003
Q28.3 Other malformations of cerebral vessels	0.000	0.997	0.003
I51.0 Cardiac septal defect, acquired	0.000	0.997	0.003
L03 Cellulitis	0.000	0.997	0.003
Q26 Congenital malformations of great veins	0.000	0.997	0.003
Q24.5 Malformation of coronary vessels	0.000	0.997	0.002
Q24.4 Congenital subaortic stenosis	0.000	0.997	0.002
Q24.3 Pulmonary infundibular stenosis	0.000	0.997	0.002
Q24.2 Cor triatriatum	0.000	0.997	0.002
Q24.1 Levocardia	0.000	0.997	0.002
Y57.6 Other diagnostic agents	0.003	0.997	0.000
C57.9 Female genital organ, unspecified	0.002	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.000	0.997	0.002
C05.1 Soft palate	0.002	0.997	0.001
H60.0 Abscess of external ear	0.000	0.997	0.002
L03.3 Cellulitis of trunk	0.000	0.997	0.003
Q24.6 Congenital heart block	0.000	0.997	0.002
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.000	0.997	0.002
I46.0 Cardiac arrest with successful resuscitation	0.000	0.997	0.003
N88.2 Stricture and stenosis of cervix uteri	0.003	0.997	0.000
Q24.0 Dextrocardia	0.000	0.997	0.002
Q28.0 Arteriovenous malformation of precerebral vessels	0.000	0.997	0.002
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.002	0.997	0.000
C53 Malignant neoplasm of cervix uteri	0.002	0.997	0.000
D22.5 Melanocytic naevi of trunk	0.000	0.998	0.002
I51.7 Cardiomegaly	0.000	0.998	0.002
Z75.1 Person awaiting admission to adequate facility elsewhere	0.000	0.998	0.002
C57.0 Fallopian tube	0.002	0.998	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.002	0.998	0.000
T14.2 Fracture of unspecified body region	0.000	0.998	0.002
T14.8 Other injuries of unspecified body region	0.000	0.998	0.002
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.000	0.998	0.002
T14.5 Injury of blood vessel(s) of unspecified body region	0.000	0.998	0.002
C57.7 Other specified female genital organs	0.002	0.998	0.000
C57.4 Uterine adnexa, unspecified	0.002	0.998	0.000
C57.3 Parametrium	0.002	0.998	0.000
C57.2 Round ligament	0.002	0.998	0.000
C57.1 Broad ligament	0.002	0.998	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.002	0.998	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.002	0.998	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
H60.2 Malignant otitis externa	0.000	0.998	0.002
Q27.1 Congenital renal artery stenosis	0.000	0.998	0.002
Q28.9 Congenital malformation of circulatory system, unspecified	0.000	0.998	0.002
Q28.8 Other specified congenital malformations of circulatory system	0.000	0.998	0.002
Q28.1 Other malformations of precerebral vessels	0.000	0.998	0.002
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
C57.8 Overlapping lesion of female genital organs	0.002	0.998	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.998	0.002
D80.8 Other immunodeficiencies with predominantly antibody defects	0.002	0.998	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.000	0.998	0.002
O64.1 Obstructed labour due to breech presentation	0.000	0.998	0.002
Q21 Congenital malformations of cardiac septa	0.000	0.998	0.002
D33.3 Cranial nerves	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
J69.0 Pneumonitis due to food and vomit	0.000	0.998	0.002
Q21.3 Tetralogy of Fallot	0.000	0.998	0.002
Q27.4 Congenital phlebectasia	0.000	0.998	0.002
Q27.2 Other congenital malformations of renal artery	0.000	0.998	0.002
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.000	0.998	0.002
T14.3 Dislocation, sprain and strain of unspecified body region	0.000	0.998	0.002
I46 Cardiac arrest	0.000	0.998	0.002
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.000	0.998	0.002
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
Z85.6 Personal history of leukaemia	0.002	0.998	0.000
J98.4 Other disorders of lung	0.000	0.998	0.002
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
Q25 Congenital malformations of great arteries	0.000	0.998	0.002
Q21.9 Congenital malformation of cardiac septum, unspecified	0.000	0.998	0.002
Q26.9 Congenital malformation of great vein, unspecified	0.000	0.998	0.002
Q26.8 Other congenital malformations of great veins	0.000	0.998	0.002
Q26.6 Portal vein-hepatic artery fistula	0.000	0.998	0.002
Q26.5 Anomalous portal venous connexion	0.000	0.998	0.002
Q26.3 Partial anomalous pulmonary venous connexion	0.000	0.998	0.002
Q26.2 Total anomalous pulmonary venous connexion	0.000	0.998	0.002
Q26.1 Persistent left superior vena cava	0.000	0.998	0.002
Q26.0 Congenital stenosis of vena cava	0.000	0.998	0.002
Q38.0 Congenital malformations of lips, not elsewhere classified	0.002	0.998	0.000
Z48.0 Attention to surgical dressings and sutures	0.002	0.998	0.000
Q21.8 Other congenital malformations of cardiac septa	0.000	0.998	0.002
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.998	0.000
M62.86 Other specified disorders of muscle (Lower leg)	0.002	0.998	0.000
M62.82 Other specified disorders of muscle (Upper arm)	0.002	0.998	0.000
C53.0 Endocervix	0.002	0.998	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.002	0.998	0.000
D84.9 Immunodeficiency, unspecified	0.002	0.998	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.000	0.998	0.002
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.000	0.998	0.002
Q20.6 Isomerism of atrial appendages	0.000	0.998	0.002
Q20.5 Discordant atrioventricular connexion	0.000	0.998	0.002
Q20.4 Double inlet ventricle	0.000	0.998	0.002
Q20.3 Discordant ventriculoarterial connexion	0.000	0.998	0.002
Q20.2 Double outlet left ventricle	0.000	0.998	0.002
Q20.1 Double outlet right ventricle	0.000	0.998	0.002
Q20.0 Common arterial trunk	0.000	0.998	0.002
R94.4 Abnormal results of kidney function studies	0.000	0.998	0.002
D84 Other immunodeficiencies	0.002	0.998	0.000
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.000	0.998	0.002
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.998	0.002
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
C53.8 Overlapping lesion of cervix uteri	0.002	0.998	0.000
C53.1 Exocervix	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.000	0.998	0.002
T14.21 Fracture of unspecified body region (open)	0.000	0.998	0.002
T14.20 Fracture of unspecified body region (closed)	0.000	0.998	0.002
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.998	0.002
M62.8 Other specified disorders of muscle	0.002	0.998	0.000
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.000	0.998	0.002
D82 Immunodeficiency associated with other major defects	0.002	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.998	0.002
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.000	0.998	0.002
R44.3 Hallucinations, unspecified	0.000	0.998	0.002
D83 Common variable immunodeficiency	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.002	0.998	0.000
L03.9 Cellulitis, unspecified	0.000	0.998	0.002
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.000	0.998	0.002
Q22.8 Other congenital malformations of tricuspid valve	0.000	0.998	0.002
Q22.6 Hypoplastic right heart syndrome	0.000	0.998	0.002
Q22.4 Congenital tricuspid stenosis	0.000	0.998	0.002
Q22.3 Other congenital malformations of pulmonary valve	0.000	0.998	0.002
Q22.2 Congenital pulmonary valve insufficiency	0.000	0.998	0.002
Q22.0 Pulmonary valve atresia	0.000	0.998	0.002
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.000	0.998	0.002
K61.0 Anal abscess	0.002	0.998	0.000
Q21.4 Aortopulmonary septal defect	0.000	0.998	0.002
Q21.2 Atrioventricular septal defect	0.000	0.998	0.002
I44.4 Left anterior fascicular block	0.000	0.998	0.002
Q38.4 Congenital malformations of salivary glands and ducts	0.002	0.998	0.000
Q38.3 Other congenital malformations of tongue	0.002	0.998	0.000
Q38.2 Macroglossia	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.002	0.998	0.000
Q25.6 Stenosis of pulmonary artery	0.000	0.998	0.002
Q38.5 Congenital malformations of palate, not elsewhere classified	0.002	0.998	0.000
Q22.1 Congenital pulmonary valve stenosis	0.000	0.998	0.002
S29.9 Unspecified injury of thorax	0.000	0.998	0.002
M79.28 Neuralgia and neuritis, unspecified (Other)	0.002	0.998	0.000
I46.1 Sudden cardiac death, so described	0.000	0.998	0.002
Q07.0 Arnold-Chiari syndrome	0.000	0.998	0.002
Q38.1 Ankyloglossia	0.002	0.998	0.000
I30-I52 Other forms of heart disease	0.000	0.998	0.002
I30.1 Infective pericarditis	0.000	0.998	0.002
Q38.8 Other congenital malformations of pharynx	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
I51.8 Other ill-defined heart diseases	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
Q22.5 Ebstein's anomaly	0.000	0.998	0.002
Q25.9 Congenital malformation of great arteries, unspecified	0.000	0.998	0.002
Q25.8 Other congenital malformations of great arteries	0.000	0.998	0.002
Q25.7 Other congenital malformations of pulmonary artery	0.000	0.998	0.002
Q25.5 Atresia of pulmonary artery	0.000	0.998	0.002
Q25.2 Atresia of aorta	0.000	0.998	0.002
D82.1 Di George's syndrome	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
I44 Atrioventricular and left bundle-branch block	0.000	0.998	0.002
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.002	0.998	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
I47 Paroxysmal tachycardia	0.000	0.998	0.002
M62.80 Other specified disorders of muscle (Multiple sites)	0.002	0.998	0.000
Q54.1 Hypospadias, penile	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
M76.67 Achilles tendinitis (Ankle and foot)	0.002	0.998	0.000
D83.9 Common variable immunodeficiency, unspecified	0.002	0.998	0.000
D84.1 Defects in the complement system	0.002	0.998	0.000
M18.1 Other primary arthrosis of first carpometacarpal joint	0.000	0.998	0.002
Q25.3 Stenosis of aorta	0.000	0.998	0.002
M62.84 Other specified disorders of muscle (Hand)	0.002	0.998	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.998	0.002
J17.2 Pneumonia in mycoses	0.000	0.998	0.002
K80.0 Calculus of gallbladder with acute cholecystitis	0.002	0.998	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.002	0.998	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.002	0.998	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.002	0.998	0.000
D82.2 Immunodeficiency with short-limbed stature	0.002	0.998	0.000
D82.0 Wiskott-Aldrich syndrome	0.002	0.998	0.000
Q21.0 Ventricular septal defect	0.000	0.998	0.002
Q25.4 Other congenital malformations of aorta	0.000	0.998	0.001
Q27.3 Peripheral arteriovenous malformation	0.000	0.998	0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
I30 Acute pericarditis	0.000	0.998	0.002
N88 Other noninflammatory disorders of cervix uteri	0.002	0.998	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.002	0.998	0.000
D83.8 Other common variable immunodeficiencies	0.001	0.998	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.001	0.998	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.001	0.998	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.001	0.998	0.000
H60.8 Other otitis externa	0.000	0.998	0.001
N88.1 Old laceration of cervix uteri	0.002	0.998	0.000
N88.0 Leukoplakia of cervix uteri	0.002	0.998	0.000
Q25.1 Coarctation of aorta	0.000	0.998	0.001
M62.87 Other specified disorders of muscle (Ankle and foot)	0.002	0.998	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.002	0.998	0.000
Q25.0 Patent ductus arteriosus	0.000	0.998	0.001
Y59.0 Viral vaccines	0.002	0.998	0.000
I43 Cardiomyopathy in diseases classified elsewhere	0.000	0.998	0.002
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
I50.9 Heart failure, unspecified	0.000	0.998	0.002
Q54.8 Other hypospadias	0.000	0.998	0.002
M54.50 Low back pain (Multiple sites in spine)	0.002	0.998	0.000
S72.30 Fracture of shaft of femur (closed)	0.002	0.998	0.000
D81.9 Combined immunodeficiency, unspecified	0.001	0.998	0.000
D81.8 Other combined immunodeficiencies	0.001	0.998	0.000
D81.7 Major histocompatibility complex class II deficiency	0.001	0.998	0.000
D81.6 Major histocompatibility complex class I deficiency	0.001	0.998	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.001	0.998	0.000
D81.4 Nezelof's syndrome	0.001	0.998	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.001	0.998	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.001	0.998	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.001	0.998	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.001	0.998	0.000
D84.8 Other specified immunodeficiencies	0.001	0.998	0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
C69 Malignant neoplasm of eye and adnexa	0.000	0.998	0.002
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
F10.4 Withdrawal state with delirium	0.000	0.998	0.002
J35.0 Chronic tonsillitis	0.002	0.998	0.000
M62.83 Other specified disorders of muscle (Forearm)	0.001	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
C70 Malignant neoplasm of meninges	0.000	0.998	0.001
I52 Other heart disorders in diseases classified elsewhere	0.000	0.998	0.002
I48 Atrial fibrillation and flutter	0.000	0.998	0.002
I41 Myocarditis in diseases classified elsewhere	0.000	0.998	0.002
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.000	0.998	0.002
I32 Pericarditis in diseases classified elsewhere	0.000	0.998	0.002
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.000	0.998	0.002
I44.3 Other and unspecified atrioventricular block	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.998	0.000
Y44.7 Plasma substitutes	0.001	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
I43.1 Cardiomyopathy in metabolic diseases	0.000	0.998	0.001
N88.4 Hypertrophic elongation of cervix uteri	0.001	0.998	0.000
Y44.6 Natural blood and blood products	0.001	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.001	0.998	0.000
G96.0 Cerebrospinal fluid leak	0.002	0.998	0.000
I44.5 Left posterior fascicular block	0.000	0.998	0.001
N04.9 Unspecified	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.998	0.000
Y59.2 Protozoal vaccines	0.001	0.998	0.000
Y59.1 Rickettsial vaccines	0.001	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.000	0.998	0.001
J17 Pneumonia in diseases classified elsewhere	0.000	0.998	0.002
Q54 Hypospadias	0.000	0.998	0.002
M76.66 Achilles tendinitis (Lower leg)	0.001	0.998	0.000
S52.00 Fracture of upper end of ulna (closed)	0.002	0.998	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.998	0.002
K51.0 Ulcerative (chronic) enterocolitis	0.002	0.998	0.000
L50.8 Other urticaria	0.000	0.998	0.001
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.000	0.998	0.002
Q54.9 Hypospadias, unspecified	0.000	0.998	0.001
Y53.6 Antidiarrhoeal drugs	0.001	0.998	0.000
Y59.3 Immunoglobulin	0.001	0.998	0.000
Z93.3 Colostomy status	0.000	0.998	0.002
I40 Acute myocarditis	0.000	0.998	0.001
K80 Cholelithiasis	0.002	0.998	0.000
Y58 Bacterial vaccines	0.001	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
D05.0 Lobular carcinoma in situ	0.002	0.998	0.000
M15.2 Bouchard's nodes (with arthropathy)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations